← Open Payments lookup

MANJINDER KAUR: Open Payments

NPI 1073170973 · PARAMUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$684 in 15 payments from 6 companies in 2025. Trend: 2023 $126 · 2024 $287 · 2025 $684

Food & beverage: $684
CompanyPaymentsAmount
GlaxoSmithKline, LLC.7$207
ABBVIE INC.1$128
Novo Nordisk Inc1$125
Gilead Sciences, Inc.1$125
ARS Pharmaceuticals Operations, Inc.3$60
Lilly USA, LLC2$38

Products named: NUCALA, BOTOX, Ozempic, Biktarvy, NEFFY, ZEPBOUND, TRELEGY ELLIPTA.

Industry payments across NJ — which companies pay providers there.